GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eurobio Scientific (XPAR:ALERS) » Definitions » Gross-Profit-to-Asset %

Eurobio Scientific (XPAR:ALERS) Gross-Profit-to-Asset % : 21.27% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Eurobio Scientific Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Eurobio Scientific's annualized Gross Profit for the quarter that ended in Dec. 2023 was €67.0 Mil. Eurobio Scientific's average Total Assets over the quarter that ended in Dec. 2023 was €314.8 Mil. Therefore, Eurobio Scientific's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 21.27%.


Eurobio Scientific Gross-Profit-to-Asset % Historical Data

The historical data trend for Eurobio Scientific's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurobio Scientific Gross-Profit-to-Asset % Chart

Eurobio Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.49 87.43 53.82 26.36 17.77

Eurobio Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.61 0.26 52.10 14.91 21.27

Competitive Comparison of Eurobio Scientific's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Eurobio Scientific's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurobio Scientific's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eurobio Scientific's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Eurobio Scientific's Gross-Profit-to-Asset % falls into.



Eurobio Scientific Gross-Profit-to-Asset % Calculation

Eurobio Scientific's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=57.488/( (330.731+316.329)/ 2 )
=57.488/323.53
=17.77 %

Eurobio Scientific's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=66.96/( (313.179+316.329)/ 2 )
=66.96/314.754
=21.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Eurobio Scientific Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Eurobio Scientific's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurobio Scientific (XPAR:ALERS) Business Description

Traded in Other Exchanges
Address
63-65 Boulevard Massena, Paris, FRA, 75013
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.

Eurobio Scientific (XPAR:ALERS) Headlines

No Headlines